RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $992,976 | +71698.7% | 1,152,212 | 0.0% | 0.05% | -17.2% |
| Q2 2023 | $1,383 | -92.6% | 1,152,212 | -46.3% | 0.06% | -93.1% |
| Q1 2023 | $18,767 | -99.9% | 2,147,212 | 0.0% | 0.92% | +1.8% |
| Q4 2022 | $17,177,696 | +199.6% | 2,147,212 | +82.7% | 0.91% | +181.4% |
| Q3 2022 | $5,734,000 | -12.2% | 1,175,000 | 0.0% | 0.32% | -22.2% |
| Q2 2022 | $6,533,000 | +9.7% | 1,175,000 | 0.0% | 0.41% | +35.3% |
| Q1 2022 | $5,957,000 | -60.6% | 1,175,000 | 0.0% | 0.31% | -48.0% |
| Q4 2021 | $15,134,000 | -13.9% | 1,175,000 | 0.0% | 0.59% | -4.2% |
| Q3 2021 | $17,578,000 | -3.7% | 1,175,000 | 0.0% | 0.61% | -4.7% |
| Q2 2021 | $18,260,000 | – | 1,175,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $20,239,000 | 3.93% |
| Cormorant Asset Management, LP | 2,326,660 | $29,967,000 | 1.78% |
| BVF INC/IL | 2,957,807 | $38,097,000 | 1.38% |
| Boxer Capital, LLC | 1,175,000 | $15,134,000 | 0.59% |
| Perceptive Advisors | 4,967,238 | $63,978,000 | 0.49% |
| LUMINUS MANAGEMENT LLC | 137,428 | $1,770,000 | 0.42% |
| Logos Global Management LP | 245,161 | $3,158,000 | 0.33% |
| Old Well Partners, LLC | 13,383 | $172,000 | 0.11% |
| Lumina Fund Management LLC | 6,000 | $77,000 | 0.02% |
| Woodline Partners LP | 119,700 | $1,542,000 | 0.02% |